Company intelligence / Profile preview

Jilin Aodong Pharmaceutical Group Co., Ltd.

Ownership: Private
Development stage: Commercial

Overview

Jilin Aodong has a broad commercial portfolio with over 300 formulations including both traditional Chinese medicine and modern pharmaceuticals. Several key products are approved for use in China across a range of indications such as hepatitis B and diabetes mellitus. The company has reported strong financial growth with CNY ~3.2 billion revenue in the latest year and net profit of CNY ~400 million. Clinical trials have been conducted for bioequivalence studies and post-marketing safety.

Therapeutic areas: NephrologyPulmonologyEndocrinologyWomen's HealthOtherDermatologyRheumatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecule drugsherbal medicinesbiochemical medicinesplant chemical medicines
Industry: Biotech

Drug pipeline

7 assets

Shengmai Liquid

6 more assets in the full pipeline.

Request access →

Partnerships

Minor stake (~5%) investment in Vital Therapies Inc., San Diego-based liver treatment company (2011)

Beyond the preview

Go deeper on Jilin Aodong Pharmaceutical Group Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jilin Aodong Pharmaceutical Group Co., Ltd..

Explore the full profile